[HTML][HTML] Prevalence and clinical aspects of depression in Parkinson's disease: a systematic review and meta‑analysis of 129 studies

S Cong, C Xiang, S Zhang, T Zhang, H Wang… - … & Biobehavioral Reviews, 2022 - Elsevier
Depression is one of the most important non-motor symptoms in Parkinson's disease (PD),
but its prevalence and related clinical characteristics are unclear. To this end, we performed …

Neurobiology of depression in Parkinson's disease: Insights into epidemiology, molecular mechanisms and treatment strategies

MH Ahmad, MA Rizvi, M Ali, AC Mondal - Ageing research reviews, 2023 - Elsevier
Parkinson's disease (PD) is characterized mainly by motor dysfunctions due to the
progressive loss of dopaminergic neurons. However, PD patients experience a multitude of …

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

J O'Brien, JP Taylor, C Ballard, RA Barker… - Journal of Neurology …, 2020 - jnnp.bmj.com
Visual hallucinations are common in older people and are especially associated with
ophthalmological and neurological disorders, including dementia and Parkinson's disease …

Probiotics treatment improves hippocampal dependent cognition in a rodent model of Parkinson's disease

C Xie, AA Prasad - Microorganisms, 2020 - mdpi.com
Parkinson's disease (PD) is a neurological disorder with motor dysfunction and a number of
psychiatric symptoms. Symptoms such as anxiety and cognitive deficits emerge prior to …

Mood disorders and anxiety in Parkinson's disease: Current concepts

H Lintel, T Corpuz, SUR Paracha… - Journal of geriatric …, 2021 - journals.sagepub.com
Mood disorders and anxiety significantly impact the prognosis and disease course of
Parkinson's disease. Non-motor symptoms of Parkinson's disease such as apathy …

[HTML][HTML] Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease?

P Jenner, A Mori, T Kanda - Parkinsonism & Related Disorders, 2020 - Elsevier
Abstract Treatment of non-motor symptoms of Parkinson's disease (PD) is a major unmet
need. Targeting adenosine A 2A receptors may address some of the neuropsychiatric …

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review

E Angelopoulou, E Stanitsa, CC Karpodini, A Bougea… - Medicina, 2023 - mdpi.com
Depression represents one of the most common non-motor disorders in Parkinson's disease
(PD) and it has been related to worse life quality, higher levels of disability, and cognitive …

Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson's disease patients

X Shi, J Zheng, J Ma, D Li, Q Gu, S Chen, Z Wang… - Neurological …, 2023 - Springer
Background Insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) exert
neuroprotective effects in Parkinson's disease (PD). To date, studies on the relationships …

Psychotherapy for the treatment of anxiety and depression in patients with Parkinson disease: a meta-analysis of randomized controlled trials

CT Hong, S Tan, TW Huang - Journal of the American Medical Directors …, 2021 - Elsevier
Objective Anxiety and depression are major psychiatric nonmotor symptoms (NMSs) of
Parkinson disease (PD). Although several studies have investigated the effects of …

[HTML][HTML] Current treatment of behavioral and cognitive symptoms of Parkinson's disease

I Rektorova - Parkinsonism & Related Disorders, 2019 - Elsevier
Cognitive and behavioral symptoms are common in Parkinson's disease, may occur even in
the prodromal stages of the disease, worsen with disease progression, and surpass motor …